Status:
UNKNOWN
Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19)
Lead Sponsor:
Trabzon Kanuni Education and Research Hospital
Conditions:
SARS-CoV2 Infection
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
Primary purpose: To investigate the effect of propolis, a food supplement product, on healing parameters in patients with COVID 19. Secondary purpose: To provide a new supportive treatment in Covid 19...
Eligibility Criteria
Inclusion
- Patients over the age of 18 who do not need a ventilator who are inpatient in the Covid service
- Patients under the age of 60 who do not need a ventilator who are inpatient in the Covid service
Exclusion
- patients do not have oral intake
- patients whose informed consent form is not approved
- patients who need a ventilator
- pregnant women
- children
Key Trial Info
Start Date :
May 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04916821
Start Date
May 15 2021
End Date
August 15 2021
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Trabzon Faculty of Medicine , Health Science University
Trabzon, Turkey (Türkiye), 61080